Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lantern Pharma Inc.

    NASDAQ: LTRN · Real-Time Price · USD
    3.18
    0.04 (1.27%)
    At close: Jun 27, 2025, 3:59 PM
    3.20
    0.63%
    After-hours: Jun 27, 2025, 05:26 PM EDT

    Lantern Pharma Statistics

    Share Statistics

    Lantern Pharma has 10.78M shares outstanding. The number of shares has increased by 0.24% in one year.

    Shares Outstanding

    n/a
    		 10.78M

    Shares Change (YoY)

    n/a
    		 0.24%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 23.23%

    Shares Floating

    n/a
    		 8.16M

    Failed to Deliver (FTD) Shares

    n/a
    		 81

    FTD / Avg. Volume

    n/a
    		 0.15%

    Short Selling Information

    The latest short interest is 266.17K, so 2.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 266.17K

    Short % of Shares Out

    n/a
    		 2.47%

    Short % of Float

    n/a
    		 2.8%

    Short Ratio (days to cover)

    n/a
    		 2.9

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -2.03

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -1.93

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lantern Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.01

    Quick Ratio

    n/a
    		 0.01

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-865,883,875

    Employee Count

    n/a
    		 24

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -31.06% in the last 52 weeks. The beta is 1.54, so Lantern Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.54

    52-Week Price Change

    n/a
    		 -31.06%

    50-Day Moving Average

    n/a
    		 3.44

    200-Day Moving Average

    n/a
    		 3.66

    Relative Strength Index (RSI)

    n/a
    		 45.22

    Average Volume (20 Days)

    n/a
    		 53,535

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -22.22B

    Net Income

    n/a
    		 -20.78B

    EBITDA

    n/a
    		 -20.59M

    EBIT

    n/a
    		 -20.78M

    Earnings Per Share (EPS)

    n/a
    		 -1930.92
    Full Income Statement

    Balance Sheet

    The company has 7.51M in cash and 243.66K in debt, giving a net cash position of 7.27M.

    Cash & Cash Equivalents

    n/a
    		 7.51M

    Total Debt

    n/a
    		 243.66K

    Net Cash

    n/a
    		 7.27M

    Retained Earnings

    n/a
    		 -76.03B

    Total Assets

    n/a
    		 21.1M

    Working Capital

    n/a
    		 16.54M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -17.81M and capital expenditures -12.6K, giving a free cash flow of -17.83M.

    Operating Cash Flow

    n/a
    		 -17.81M

    Capital Expenditures

    n/a
    		 -12.6K

    Free Cash Flow

    n/a
    		 -17.83M

    FCF Per Share

    n/a
    		 -1.66
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LTRN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LTRN is $25, which is 698.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $25

    Price Target Difference

    n/a
    		 698.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.21

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist